Medicine: New immunotherapy ‘highly effective’ against hepatitis B
Scientists at UCL have identified a new immunotherapy to combat the hepatitis B virus (HBV), the most common cause of liver cancer in the world. London, May 17, 2021.- Each year, globally, chronic HBV causes an estimated 880,000 deaths from liver cirrhosis and hepatocellular carcinoma/liver cancer (HCC). The pioneering studyContinuar Leyendo















